Observational analysis highlights improved quality of life in AML patients on venetoclax with palliative care, suggesting needs for EOL care enhancement.
Key Points
Hospice enrollment increased to 66% with palliative care compared to 44% without, indicating improved end of life care.
Patients receiving palliative care experienced similar aggressive end of life care rates compared to those without, at 77% versus 79%.
Utilizing data from 160 AML patients treated with venetoclax-based therapy, this study assessed palliative care impact on quality of life and EOL care patterns.
Disparities in palliative care access among gender, race, and insurance status call for ongoing efforts to refine end of life care strategies.